Document is current

Any future updates will be listed below

Verapamil erhält länger die Betazellfunktion bei neu manifestiertem Typ-1-Diabetes

Crossref DOI link: https://doi.org/10.1007/s15034-022-3852-z

Published Online: 2022-06-23

Published Print: 2022-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark